Novozymes AS (NZYM B):企業の財務・戦略的SWOT分析

◆英語タイトル:Novozymes AS (NZYM B) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH31878FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Novozymes AS (NZYM B) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Novozymes AS (Novozymes) is a biotechnology company that produces and sells industrial enzymes and microorganisms. The company provides enzymes for detergents, technical, food and feed industries. It supplies a range of microorganisms for use in agriculture, industrial cleaning and wastewater treatment; and bio innovation solutions to minimize the CO2 emissions. Novozymes’s products also find applications in hand and automatic dishwashing soaps, laundry detergents and professional cleaning products. It conducts research and development (R&D), production, and sale and marketing operations through subsidiaries such as Novozymes BioAg SA, Novozymes Latin America Ltda, Novozymes BioAg AS and Novozymes Nederland BV. The company has operational presence spanning across Europe, the Middle East, Africa, North America, Asia-Pacific and Latin America. Novozymes is headquartered in Bagsvaerd, Denmark.

Novozymes AS Key Recent Developments

Feb 02,2021: Novozymes delivers resilient full-year results despite the COVID-19 pandemic and is confident about getting back to growth in 2021
Dec 18,2020: Novozymes to buy U.S. probiotics maker Microbiome Labs
Nov 26,2020: Novozymes: Morten Enggaard Rasmussen appointed new Executive Vice President of People, Sustainability & Brand
Nov 23,2020: Amy Byrick appointed new Executive Vice President of Strategy & Business Transformation
Sep 28,2020: Novozymes launches Fibrex platform for corn fiber to ethanol

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Novozymes AS – Key Facts
Novozymes AS – Key Employees
Novozymes AS – Key Employee Biographies
Novozymes AS – Major Products and Services
Novozymes AS – History
Novozymes AS – Company Statement
Novozymes AS – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Novozymes AS – Business Description
Business Segment: Agriculture and Animal Health
Overview
Performance
Business Segment: Bioenergy
Overview
Performance
Business Segment: Food, Beverages and Human Health
Overview
Performance
Business Segment: Grain and Tech Processing
Overview
Performance
Business Segment: Household Care
Overview
Performance
Geographical Segment: Asia-Pacific
Performance
Geographical Segment: Denmark
Performance
Geographical Segment: Latin America
Performance
Geographical Segment: North America
Performance
Geographical Segment: Rest of Europe, Middle-East and Africa
Performance
R&D Overview
Novozymes AS – Corporate Strategy
Novozymes AS – SWOT Analysis
SWOT Analysis – Overview
Novozymes AS – Strengths
Novozymes AS – Weaknesses
Novozymes AS – Opportunities
Novozymes AS – Threats
Novozymes AS – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Novozymes AS, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Novozymes AS, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Novozymes AS, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 02, 2021: Novozymes delivers resilient full-year results despite the COVID-19 pandemic and is confident about getting back to growth in 2021
Nov 26, 2020: Novozymes: Morten Enggaard Rasmussen appointed new Executive Vice President of People, Sustainability & Brand
Nov 23, 2020: Amy Byrick appointed new Executive Vice President of Strategy & Business Transformation
Sep 28, 2020: Novozymes launches Fibrex platform for corn fiber to ethanol
Aug 25, 2020: Novozymes bids coal goodbye in Kalundborg
Aug 14, 2020: Novozymes delivers solid first half-year of 2020
Aug 11, 2020: Novozymes: Interim report for the first half of 2020
Feb 26, 2020: Novozymes A/S annual shareholders’ meeting 2020
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Novozymes AS, Key Facts
Novozymes AS, Key Employees
Novozymes AS, Key Employee Biographies
Novozymes AS, Major Products and Services
Novozymes AS, History
Novozymes AS, Subsidiaries
Novozymes AS, Key Competitors
Novozymes AS, Ratios based on current share price
Novozymes AS, Annual Ratios
Novozymes AS, Annual Ratios (Cont...1)
Novozymes AS, Annual Ratios (Cont...2)
Novozymes AS, Interim Ratios
Novozymes AS, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Novozymes AS, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Novozymes AS, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Novozymes AS (NZYM B):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Midas Group Ltd:企業の戦略・SWOT・財務情報
    Midas Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Midas Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Cherkizovo Group OJSC (GCHE):企業の財務・戦略的SWOT分析
    Cherkizovo Group OJSC (GCHE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Aquila Resources Ltd:企業の戦略・SWOT・財務分析
    Aquila Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Aquila Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Drake & Scull International (DSI):企業の財務・戦略的SWOT分析
    Drake & Scull International (DSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • CITIC Securities Company Limited:戦略・SWOT・企業財務分析
    CITIC Securities Company Limited - Strategy, SWOT and Corporate Finance Report Summary CITIC Securities Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Tampa Electric Co:電力:M&Aディール及び事業提携情報
    Summary Tampa Electric Company (TEC), a subsidiary of Emera Inc., is an energy utility. It conducts the generation, purchase, transmission, distribution and sale of electricity and the distribution, purchase and sale of natural gas in Florida. The service area for electric operations covers West Cen …
  • G4S plc:企業のM&A・事業提携・投資動向
    G4S plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's G4S plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Trina Solar Ltd-エネルギー分野:企業M&A・提携分析
    Summary Trina Solar Ltd (Trina Solar) is a vertically-integrated solar power products manufacturer. The company manufactures a wide variety of PV modules, both monocrystalline and multicrystalline; ingots, wafers, cells and solar modules. The company also designs, constructs, sells and operates sola …
  • Colt’s Manufacturing Company LLC:企業の戦略的SWOT分析
    Colt's Manufacturing Company LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • 3i Infotech Ltd (3IINFOTECH):企業の財務・戦略的SWOT分析
    3i Infotech Ltd (3IINFOTECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Corizon Health Inc:企業の戦略的SWOT分析
    Corizon Health Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Patel Engineering Ltd:企業の戦略・SWOT・財務分析
    Patel Engineering Ltd - Strategy, SWOT and Corporate Finance Report Summary Patel Engineering Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Aimmune Therapeutics Inc (AIMT):企業の財務・戦略的SWOT分析
    Summary Aimmune Therapeutics Inc (Aimmune) formerly Allergen Research Corp is a clinical-stage biopharmaceutical company that develops proprietary product candidates for the treatment of peanut and other food allergies. The company’s lead product candidate AR101 is used to treat the peanut allergy. …
  • MDC Holdings Inc:企業の戦略・SWOT・財務情報
    MDC Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary MDC Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Grupo Herdez SA de CV:企業の戦略・SWOT・財務情報
    Grupo Herdez SA de CV - Strategy, SWOT and Corporate Finance Report Summary Grupo Herdez SA de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Faes Farma SA (FAE):製薬・医療:M&Aディール及び事業提携情報
    Summary Faes Farma SA (Faes Farma) develops, manufactures and commercializes pharmaceutical products and raw materials. The company offers prescription drugs, generic drugs, food supplements, over-the-counter (OTC) medications, baby foods, skin-care treatment products. It exports raw-materials and f …
  • Bellco Srl:医療機器:M&Aディール及び事業提携情報
    Summary Bellco Srl (Bellco), a subsidiary of Medtronic plc, is a biotechnology company that offers hemodialysis solutions. The company provides chronic line, acute line and neonatal patient products. Its chronic line products comprise haemodiafiltration therapies and dialysis machines, among others. …
  • Thaivivat Insurance Public Company Limited:企業の戦略・SWOT・財務分析
    Thaivivat Insurance Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Thaivivat Insurance Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Southern Co (SO):企業の財務・戦略的SWOT分析
    Southern Co (SO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • China Vanke Co., Ltd.:企業のM&A・事業提携・投資動向
    China Vanke Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Vanke Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆